# Clinical Study of Reduning Injection for the Treatment of Influenza in Children

> **NCT04183725** · PHASE4 · UNKNOWN · sponsor: **China Academy of Chinese Medical Sciences** · enrollment: 240 (estimated)

## Conditions studied

- Influenza in Children

## Interventions

- **DRUG:** Reduning injection
- **DRUG:** Oseltamivir phosphate granules

## Key facts

- **NCT ID:** NCT04183725
- **Lead sponsor:** China Academy of Chinese Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-12-01
- **Primary completion:** 2021-06-01
- **Final completion:** 2021-12-31
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2019-12-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04183725

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04183725, "Clinical Study of Reduning Injection for the Treatment of Influenza in Children". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04183725. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*